Note 9 - Segment Information and Disaggregated Revenue (Tables)

9 Months Ended

Mar. 31, 2024

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

		Sales, Net						Segment
		U.S.		International				Gross					Capital
		Customers		Customers		Total		Profit (loss)			Depreciation		Expenditures
Contract Manufacturing	2024	$	10,770	$	2,980	$	12,750	$	1,250		$	77	$	345
	2023		10,417		2,180		12,597		978			86		16
Other Nutraceutical Businesses	2024		397		-		397		(2	)		-		-
	2023		493		8		501		30			-		-
Total Company	2024		11,167		1,980		13,147		1,248			77		345
	2023		10,910		2,188		13,098		1,008			86		16

		Sales, Net						Segment
		U.S.		International				Gross				Capital
		Customers		Customers		Total		Profit		Depreciation		Expenditures
Contract Manufacturing	2024	$	31,022	$	5,218	$	36,240	$	2,563	$	231	$	404
	2023		29,272		6,568		35,840		2,745		265		98
Other Nutraceutical Businesses	2024		1,304		27		1,331		37		1		3
	2023		1,830		8		1,838		330		2		-
Total Company	2024		32,326		5,245		37,571		2,600		232		407
	2023		31,102		6,576		37,678		3,075		267		98

	Total Assets as of
	March 31,		June 30,
	2024		2023
Contract Manufacturing	$	21,097	$	19,507
Other Nutraceutical Businesses		5,845		5,924
Total Company	$	26,942	$	25,431